KeyBanc analyst Aleksey Yefremov lowered the firm’s price target on Eastman Chemical to $103 from $106 and keeps an Overweight rating on the shares. The firm continues to believe in the longer-term earnings potential of the Eastman portfolio and the ramp of its methanolysis project, but the price target decrease reflects ongoing weakness in the company’s end-markets, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EMN: